![Logo for Ondine Biomedical Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F0a85a-2023-12-22-09-55-17.png&w=256&q=100)
Ondine Biomedical Investor Relations Material
Latest events
![Logo for Ondine Biomedical Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F0a85a-2023-12-22-09-55-17.png&w=128&q=100)
H2 2023
Ondine Biomedical
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Ondine Biomedical Inc
Access all reports
Ondine Biomedical Inc. is a life sciences company specializing in the development of photodisinfection-based therapies. These innovative therapies are designed to provide solutions for a wide range of infections, including those resistant to antibiotics. The company's focus is on creating non-antibiotic anti-infective treatments for bacterial, viral, and fungal infections, leveraging its patented light-activated technology. Ondine Biomedical Inc.'s approach represents a significant advancement in addressing the global challenge of drug-resistant infections, offering potential benefits in both healthcare settings and beyond. The company is headquartered in Vancouver, Canada, and its shares are listed on the London Stock Exchange.
Key slides for Ondine Biomedical Inc
![Ideal Characteristic](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Fondine-biomedical-inc-h2-2023-6476c574a57266f0%2F7.png&w=3840&q=75)
![Logo for Ondine Biomedical Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F0a85a-2023-12-22-09-55-17.png&w=128&q=100)
H2 2023
Ondine Biomedical Inc
![ONDINE BIOMEDICAL
P](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Fondine-biomedical-inc-h2-2023-6476c574a57266f0%2F8.png&w=3840&q=75)
![Logo for Ondine Biomedical Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F0a85a-2023-12-22-09-55-17.png&w=128&q=100)
H2 2023
Ondine Biomedical Inc
Latest articles
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2Fbbbaafadba%2Fpontis-dackmo_strong-opinions-loosely-held.png&w=3840&q=75)
Strong Opinions, Loosely Held: Pontus Dackmo on Flexibility and Market Psychology
After a two-decade career in finance, Pontus Dackmo co-founded Protean Funds Scandinavia in 2022, where he now serves as CEO and Investment Manager.
4 Sep 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2F7455f6afd1%2Fnovo-nordisk_the-danish-pharmaceutical-titan.png&w=3840&q=75)
Novo Nordisk: The Danish Pharmaceutical Titan Revolutionizing Global Healthcare
Novo Nordisk's rise to becoming Europe's largest company, reshaping global healthcare and Denmark's economy.
5 Sep 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2F5533bee49f%2Fthe-toyota-way.png&w=3840&q=75)
The Toyota Way: Revolutionizing Global Manufacturing
Explore how Toyota's Lean Manufacturing and Kaizen principles revolutionized production and quality, setting global benchmarks for excellence.
2 Sep 2024
Ticker symbol
OBI
Country
🇬🇧 United Kingdom